Defeng Xu

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Venues

Chemical biology & drug design

Drug development research

Organic letters

Journal of medicinal chemistry

Changzhou University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Changzhou University

China

Professor :: School of Pharmaceutical Engineering and Life Sciences

Shanghai Jiao Tong University

China

Deputy researcher :: School of Medicine

Publications

Yongpeng Shen, Yilin Cheng, Haotian Hu, Yufeng Liu, Yujie Li, Tianyu Zhu, Defeng Xu, Hang Hu
Synthesis and in vitro antitumor activity of galactosamine-docetaxel conjugates. Chemical biology & drug design 103 (3) (2024)
Zhe Wu, Shuqiang Chen, Zhipeng Chen, Guoqiang Dong, Defeng Xu, Chunquan Sheng
Design of Evodiamine-Glucose Conjugates with Improved In Vivo Antitumor Activity. Journal of medicinal chemistry (2024)
Jiangfei Liu, Yaohui Ni, Keyun Zhou, Guanzhao Wu, Liangyong Hu, Tianyu Zhu, Defeng Xu, Hang Hu
Synthesis of curcumin derivatives targeting androgen receptor for castration-resistant prostate cancer therapy. Chemical biology & drug design 104 (1) (2024)
Tierui Pan, Qianjia Yuan, Defeng Xu, Wanbin Zhang
Iridium-Catalyzed Asymmetric Hydrogenation of Unfunctionalized Cycloalkenes to Access Chiral 2-Aryl Tetralins. Organic letters (2024)
Yongpeng Shen, Yilin Cheng, Haotian Hu, Yufeng Liu, Yujie Li, Tianyu Zhu, Defeng Xu, Hang Hu
Synthesis and in vitro antitumor activity of galactosamine-docetaxel conjugates. Chemical biology & drug design 103 (3) (2024)
Shengping Liu, Fang Ding, Wei Xu, Liangrui Miu, Yuxiang Tang, Defeng Xu, Tianyu Zhu, Hang Hu
Biotin-new indocyanine green conjugate: Synthesis, in vitro photocytotoxicity and in vivo biodistribution. Chemical biology & drug design 103 (3) (2024)
Zhe Wu, Shuqiang Chen, Zhipeng Chen, Guoqiang Dong, Defeng Xu, Chunquan Sheng
Design of Evodiamine-Glucose Conjugates with Improved In Vivo Antitumor Activity. Journal of medicinal chemistry 67 (9) (2024)
Tierui Pan, Qianjia Yuan, Defeng Xu, Wanbin Zhang
Iridium-Catalyzed Asymmetric Hydrogenation of Unfunctionalized Cycloalkenes to Access Chiral 2-Aryl Tetralins. Organic letters 26 (27) (2024)
Shengping Liu, Fang Ding, Wei Xu, Liangrui Miu, Yuxiang Tang, Defeng Xu, Tianyu Zhu, Hang Hu
Biotin-new indocyanine green conjugate: Synthesis, in vitro photocytotoxicity and in vivo biodistribution. Chemical biology & drug design 103 (3) (2024)
Xiaoyin Yuan, Yayu Tao, Wen Xiao, Kunda Du, Hang Hu, Defeng Xu, Qingbo Xu
Conjugates of lactobionic acid and IR820: New photosensitizers for efficient photodynamic therapy of hepatoma cells. Drug development research (2022)
Hang Hu, Huan Zhou, Defeng Xu
A review of the effects and molecular mechanisms of dimethylcurcumin (ASC-J9) on androgen receptor-related diseases. Chemical biology & drug design 97 (4) (2021)
Xinxin Cui, Kunda Du, Xiaoyin Yuan, Wen Xiao, Yayu Tao, Defeng Xu, Hang Hu
A comparative study of the in vitro antitumor effect of mannose-doxorubicin conjugates with different linkers. Drug development research (2021)
Defeng Xu, Hang Hu, Jing Guan, Jun Da, Yipeng Xie, Yalin Liu, Ren Kong, Guoqiang Song, Huan Zhou
Synthesis of novel tanshinone derivatives for treatment of castration-resistant prostate cancer. Chemical biology & drug design 94 (3) (2019)
Hang Hu, Bin Wang, Chao Lai, Xiangjian Xu, Zihan Zhen, Huan Zhou, Defeng Xu
iRGD-paclitaxel conjugate nanoparticles for targeted paclitaxel delivery. Drug development research 80 (8) (2019)

Defeng Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Defeng Xu